22nd Century Group (XXII) Gross Margin

22nd Century Group (XXII) currently has a gross margin of 42.1%. Margins are contracting over recent quarters. The company is a Biotech cannabis company trading on the NASDAQ.

Current Gross Margin
42.1%
Margin Trend
Contracting
Latest Quarter Margin
46.8%

Quarterly Gross Margin

PeriodRevenueCOGSGross ProfitGross Margin
FY2025 Q4$3.5M$1.9M$1.7M46.8%
FY2025 Q3$4.0M$2.6M$1.5M36.3%
FY2025 Q2$4.1M$2.9M$1.2M29.9%
FY2025 Q1$6.0M$2.9M$3.1M51.6%
FY2024 Q4$4.0M$0$00.0%
FY2024 Q3$5.9M$0$00.0%
FY2024 Q2$7.9M$0$00.0%
FY2024 Q1$6.5M$0$00.0%
FY2023 Q4$7.4M$0$00.0%

Frequently Asked Questions

What is XXII's current gross margin?+
Gross margin for 22nd Century Group is calculated as (revenue minus cost of revenue) divided by revenue, expressed as a percentage. It measures how efficiently the company converts sales into gross profit before operating expenses. Higher margins indicate better pricing power or lower production costs.
What is a good gross margin for cannabis companies?+
Cannabis gross margins vary widely by sub-sector. Retailers typically see 40-55%, vertically integrated MSOs 45-60%, and LPs 20-45%. 22nd Century Group's margin should be compared to peers in the same sub-sector for meaningful context. Margins above 50% generally indicate strong pricing power.
Why do XXII's margins change quarter to quarter?+
Gross margin fluctuations for 22nd Century Group can result from changes in product mix, pricing pressure from competition, input cost changes (e.g., energy, labor), inventory write-downs, or scaling into new markets where initial costs are higher. Seasonal harvest patterns can also affect margins for cultivators.

More XXII Data